Cat Renal Osteodystrophy Management

Renal osteodystrophy in cats with advanced chronic kidney disease causes painful bone demineralisation and requires phosphate management and sometimes calcitriol supplementation.

Key Facts

Renal osteodystrophy results from secondary hyperparathyroidism driven by phosphate retention in CKD
Elevated parathyroid hormone causes bone resorption to maintain calcium levels, weakening skeletal integrity
Clinical signs include rubber jaw, pathological fractures, and pain on jaw palpation
Dietary phosphate restriction through renal diets reduces the drive for parathyroid hormone elevation
Intestinal phosphate binders added to food further reduce phosphate absorption in advanced disease
Calcitriol supplementation in appropriate candidates may reduce parathyroid hormone and slow bone loss

Welfare Considerations

Renal osteodystrophy causes significant welfare harm through chronic bone pain and the risk of pathological fractures that cause acute severe pain. The rubber jaw sign in severe cases represents extensive demineralisation that causes ongoing facial discomfort. Prevention through aggressive phosphate management early in the course of CKD is more effective than treating established osteodystrophy. Regular monitoring of parathyroid hormone levels in CKD cats allows early identification of secondary hyperparathyroidism before significant bone loss occurs, enabling timely intervention to protect skeletal integrity and reduce pain.

What You Can Do

Begin dietary phosphate restriction early in CKD management before osteodystrophy develops
Add intestinal phosphate binders to food if dietary restriction alone fails to control phosphate levels
Discuss calcitriol supplementation with a feline internal medicine specialist if PTH is persistently elevated
Monitor PTH levels alongside routine CKD bloodwork to detect secondary hyperparathyroidism early
Handle cats with suspected renal osteodystrophy gently to reduce fracture risk during examination